jay brophy
@brophyj.bsky.social
contrarian cardiologist; data science, watercolour and gordon setter enthusiast
Why is any Canadian academic institution still using X as a social media platform?
Last year, we made the decision to step away from X.
The Royal Irish Academy is committed to creating, convening, and sharing knowledge for the public good and as an organisation we value Independence; Integrity; Curiosity; Openness and Rigour.
In our view, X no longer aligns with these values
The Royal Irish Academy is committed to creating, convening, and sharing knowledge for the public good and as an organisation we value Independence; Integrity; Curiosity; Openness and Rigour.
In our view, X no longer aligns with these values
January 17, 2026 at 6:12 PM
Why is any Canadian academic institution still using X as a social media platform?
There must be some way to stop this nonsense.
Emails received between 0:00 to 8:00 April 28 2025
- Journal article invitations (21)
- Meetings invitations (3)
- Editorial Board invitations (1)
Emails received between 0:00 to 8:00 April 28 2025
- Journal article invitations (21)
- Meetings invitations (3)
- Editorial Board invitations (1)
April 28, 2025 at 1:09 PM
There must be some way to stop this nonsense.
Emails received between 0:00 to 8:00 April 28 2025
- Journal article invitations (21)
- Meetings invitations (3)
- Editorial Board invitations (1)
Emails received between 0:00 to 8:00 April 28 2025
- Journal article invitations (21)
- Meetings invitations (3)
- Editorial Board invitations (1)
Excellent @BMJ.com article on PLATO and ticagrelor (T). FDA refused drug approval despite P<0.001, concerns centred on data integrity and the discordance between the overall and US results, HRUS 1.27, 95%CI 0.92 - 1.75. One year later with no change in the dataset, the FDA approved the drug.
December 26, 2024 at 4:00 PM
Excellent @BMJ.com article on PLATO and ticagrelor (T). FDA refused drug approval despite P<0.001, concerns centred on data integrity and the discordance between the overall and US results, HRUS 1.27, 95%CI 0.92 - 1.75. One year later with no change in the dataset, the FDA approved the drug.
Good bye X, hello BlueSky!
November 22, 2024 at 2:52 PM
Good bye X, hello BlueSky!